Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Prodrugs

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain.

Annals of internal medicine·2017

Same author

LETTER TO THE EDITOR.

Journal of insurance medicine (New York, N.Y.)·2016

Same author

CP II.

Journal of pain & palliative care pharmacotherapy·2016

Same author

Operationalizing Pain Treatment in the Biopsychosocial Model: Take a Daily "SWEM"--Socialize, Work, Exercise, Meditate.

Journal of pain & palliative care pharmacotherapy·2015

Same author

Pain and treatment from a human primate perspective.

Journal of pain & palliative care pharmacotherapy·2014

Same author

Reconsider treatment agreements and drug testing.

Journal of pain & palliative care pharmacotherapy·2014

Search research articles

Related Experiment Video

Updated: May 25, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Profit-driven drug testing.

¹PainExhibit.com, Sacramento, California 95826, USA. Mark@PainExhibit.com

Journal of Pain & Palliative Care Pharmacotherapy

|February 15, 2012

Summary

Physicians increasingly drug test patients on opioid therapy due to concerns about misuse and legal issues. This study explores how profit incentives, including Medicare reimbursement, may also drive this common practice.

Area of Science:

Pain Management
Medical Economics
Clinical Toxicology

Background:

Random drug testing for patients on opioid therapy is increasingly common.
Physician motivations often cited include concerns over prosecution, drug misuse, addiction, and overdose.
The potential financial incentives for physicians performing drug tests have remained largely unexplored.

Purpose of the Study:

To investigate the hypothesis that profit motives influence physician decisions regarding random drug testing of patients undergoing chronic pain management.
To examine the role of financial incentives, such as Medicare reimbursement and potential kickbacks, in driving drug testing behavior.

Main Methods:

Exploration of Medicare reimbursement policies and fee structures related to drug testing.

More Related Videos

Cost-Efficient Transcriptomic-Based Drug Screening

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

Related Experiment Videos

Last Updated: May 25, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Cost-Efficient Transcriptomic-Based Drug Screening

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

Analysis of potential financial incentives and kickback schemes influencing physician practices.

Review of existing literature and physician guidelines regarding drug testing in pain management.

Main Results:

Evidence suggests that financial incentives, including Medicare reimbursement rates, may create a profit motive for physicians to conduct drug tests.
The financial benefits associated with drug testing could potentially influence the frequency and necessity of these tests.
This profit motive may coexist with, or even supersede, clinical concerns in some cases.

Conclusions:

Physician drug testing behavior in chronic pain patients may be significantly influenced by financial gain.
Understanding these economic drivers is crucial for ethical practice and patient care.
Further research is needed to quantify the impact of financial incentives on clinical decision-making in pain management and drug testing.